We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimally Invasive Lumbar Spinal Fusion

By HospiMedica staff writers
Posted on 13 Feb 2007
A percutaneous access and fusion system enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures.

The AxiaLIF (axial lumbar interbody fusion) system includes surgical instruments for creating a safe and reproducible pre-sacral access route to the L5-S1 vertebral bodies through a percutaneous opening adjacent to the sacral bone. More...
The minimally invasive approach expands the use of visualization and fluoroscopy, offering consistent and reproducible results. The surgical technique features instrumentation for the distraction and stabilization of the anterior lumbar column while mitigating the soft tissue trauma associated with traditional lumbar fusion through open surgical incisions. This approach alleviates the need for the surgeon to cut through soft tissues like muscles and ligaments, thus lessening patient pain and the likelihood of complications.

When combined with pedicle screws or facet screws, the system provides a completely percutaneous 360° fusion at L5-S1, performed within 90 minutes. The minimally invasive approach allows patients to be discharged from the hospital the day after surgery, and on average return to work in 15 days. This is a dramatic reduction in hospital lengths of stay, which can otherwise run three to four nights, followed by a one- to two-month recovery period before returning to work. The AxiaLIF is a product of TranS1 (Wilmington, NC, USA). The company has recently announced a major clinical milestone, with 1,000 patients having undergone the procedure.

"Early hospital release and a more rapid return to normal activities are the clinical deliverables we bring to our patients. In fact, surgeons are reporting that a small, and growing number of their AxiaLIF procedures are being conducted as out-patient surgery, with patients going home the same day as their spine fusion surgery,” said Rick Randall, president and CEO of TranS1. "Today, spine surgeons from 37 states and seven countries are utilizing our novel approach.”



Related Links:
TranS1

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.